Status:
COMPLETED
Efficacy of Oral Tolerance Induction to Raw Apple
Lead Sponsor:
Michel Bouvier
Collaborating Sponsors:
Polyclinique du Beaujolais
Clinique Charcot
Conditions:
Oral Allergic Syndrome
Allergic Reaction Caused by Food (Disorder)
Eligibility:
All Genders
10+ years
Brief Summary
The aim of the study was to describe an intensive ultra rush (UR) protocol of raw Golden apple (RGA) reintroduction in 28 in-patients, show the protocol's tolerance and the patients' follow-up at 2 mo...
Detailed Description
The aim of this study was to describe an intensive ultra rush (UR) protocol of raw Golden apple (RGA) reintroduction in 28 in-patients, show the protocol's tolerance and the patients' follow-up at 2 m...
Eligibility Criteria
Inclusion
- No longer eat raw rosacea for at least 6 months due to oral allergic syndrome
- With allergic rhinitis or asthma due to betulaceae pollen (SPT+ and/or IgE + to Bet v 1 \> 0,10 kUA/L)
- With reduced quality of life
Exclusion
- With severe allergic reaction to rosacea (\>Grade 3 according to Ring and Messmer's classification)
- Pregnant woman
- Uncontrolled asthma (FEV1 \< 70%)
- Immunosuppressed patient or having malignant disease, current infectious disease, or serious cardiovascular disease
- Opposed to use data
Key Trial Info
Start Date :
June 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2018
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT04116580
Start Date
June 1 2016
End Date
October 31 2018
Last Update
October 8 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.